camptothecin has been researched along with Leukemia L 1210 in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (47.17) | 18.7374 |
1990's | 23 (43.40) | 18.2507 |
2000's | 4 (7.55) | 29.6817 |
2010's | 1 (1.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamovics, JA; Hutchinson, CR | 1 |
Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL | 1 |
Kohn, KW; Manikumar, G; Nicholas, AW; Pommier, Y; Wall, ME; Wani, MC | 1 |
Bartus, JO; Caranfa, MJ; Gallagher, G; Hertzberg, RP; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; Mattern, MR; Mong, SM | 1 |
Natschke, SM; Nicholas, AW; Wall, ME; Wani, MC | 1 |
Nicholas, AW; Wall, ME; Wani, MC | 1 |
Bisagni, E; Croisy, A; Janin, YL; Riou, JF | 1 |
Besterman, JM; Leitner, P; Manikumar, G; Moore, L; Nicholas, AW; Tele, C; Truesdale, A; Wall, ME; Wani, MC | 1 |
Alajarín, R; Alvarez-Builla, J; Benito, EJ; Caignard, D; Fontana, A; Lambel-Giraudet, S; Leonce, S; Martín, MJ; Pierré, A; Sánchez, N; Vaquero, JJ | 1 |
Lang, M; Wang, Y; Xia, L; Yu, P; Zhang, G; Zhang, Z; Zhao, J | 1 |
Broggini, M; Colombo, T; Geroni, C; Marchini, S; Sabatino, MA | 1 |
Jiang, W; Larrick, JW; Li, L; Wang, Y | 1 |
Furuta, T; Miyasaka, T; Nagata, H; Sawada, S; Yaegashi, T; Yokokura, T | 1 |
Furue, H | 1 |
Furuta, T; Miyasaka, T; Sawada, S; Yaegashi, T; Yamaguchi, K; Yokokura, T | 1 |
Furuta, T; Miyasaka, T; Sawada, S; Yaegashi, T; Yokokura, T | 1 |
Kumi, R; Perez-Soler, R; Poirot, K; Reddy, S; Sugarman, SM; Wasan, K; Zou, Y | 1 |
Ganapathi, R; Grabowski, D | 1 |
Aalders, M; El-Gawly, H; Gabr, A; Kuin, A; Smets, LA | 1 |
Duraj, J; Novotný, L; Rauko, P; Sedlák, J; Szekeres, MF | 1 |
Bailly, C; Bigg, DC; Camara, J; Dassonneville, L; Demarquay, D; Kasprzyk, PG; Kiss, R; Lavergne, O; Lesueur-Ginot, L | 1 |
Bowman, KJ; Calvert, AH; Curtin, NJ; Newell, DR | 1 |
Adamson, RH; Mead, JA; Sieber, SM | 1 |
Taylor, H; Wall, ME; Wani, MC | 1 |
Bristol, JA; Comins, DL; Davenport, RW; Horwitz, SB; Kane, MJ; Lyle, RE; Maloney, JR; Portlock, DE | 1 |
Sugasawa, T; Toyoda, T; Uchida, N; Yamaguchi, K | 1 |
Furuta, T; Miyasaka, T; Nokata, K; Sawada, S; Yaegashi, T; Yokokura, T | 1 |
Capranico, G; Jaxel, C; Kerrigan, D; Kohn, KW; Pommier, Y | 1 |
Beerman, TA; McHugh, MM; Sigmund, RD | 1 |
Furuta, T; Miyasaka, T; Nokata, K; Sawada, S; Yokokura, T | 1 |
Furuta, T; Matsuoka, S; Miyasaka, T; Nagata, H; Nokata, K; Sawada, S; Yokokura, T | 1 |
Furuta, T; Yokokura, T | 2 |
Aiyama, R; Furuta, T; Miyasaka, T; Nokata, K; Okajima, S; Sawada, S; Sugino, E; Yamaguchi, K; Yokokura, T | 1 |
Darzynkiewicz, Z; Del Bino, G; Skierski, JS | 1 |
Furuta, T; Kaneda, N; Nagata, H; Yokokura, T | 1 |
Hsiang, YH; Kirschenbaum, S; Liu, LF; Manikumar, G; Nicholas, AW; Potmesil, M; Silber, R; Wall, ME; Wani, MC | 1 |
Hsiang, YH; Lihou, MG; Liu, LF | 1 |
Hsiang, YH; Liu, LF | 1 |
Bartus, HF; Crooke, ST; Johnson, RK; Mattern, MR; Mirabelli, CK; Mong, SM | 1 |
Baba, H; Kunimoto, T; Miyasaka, T; Mutai, M; Nitta, K; Sawada, S; Takeuchi, M; Tanaka, T; Uehara, N; Yokokura, T | 2 |
Manikumar, G; Nicholas, AW; Wall, ME; Wani, MC | 1 |
Fukada, M; Furuta, T; Kaneda, N; Miyasaka, T; Nagata, H; Notake, K; Sawada, S; Yokokura, T | 1 |
Kann, HE; Kohn, KW | 1 |
Gang, M; Kline, I; Sirica, AE; Venditti, JM; Woodman, RJ | 1 |
Kline, I | 1 |
Brockman, RW | 1 |
Horwitz, SB | 1 |
Bhuyan, BK; Fraser, TJ; Li, LH; Olin, EJ | 1 |
Homan, ER; Neil, GL | 1 |
Bhuyan, BK; Fraser, TJ; Gray, LG; Kuentzel, SL; Neil, GL | 1 |
Dysard, R; Kessel, D | 1 |
4 review(s) available for camptothecin and Leukemia L 1210
Article | Year |
---|---|
[Irinotecan hydrochloride (CPT-11)].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Leukemia L1210; Lung Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1994 |
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
Biochemical aspects of drug combinations.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Division; Cytarabine; Deferoxamine; Diamines; DNA, Neoplasm; Doxorubicin; Drug Therapy, Combination; Leukemia L1210; Macromolecular Substances; Mice; Neoplasms; Neoplasms, Experimental; Nitrosourea Compounds; Purine Nucleotides; Ribonucleotide Reductases; Thioguanine; Triazoles | 1974 |
Novel inhibitors of RNA synthesis.
Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Benzoates; Benzodiazepinones; Bleomycin; Camptothecin; Centrifugation, Density Gradient; Cycloparaffins; Depression, Chemical; DNA; DNA Replication; DNA-Directed RNA Polymerases; Escherichia coli; HeLa Cells; Lactones; Leukemia L1210; Mitosis; Nucleic Acid Denaturation; Pyrroles; RNA; RNA, Ribosomal; RNA, Viral; Structure-Activity Relationship; Templates, Genetic; Uracil Nucleotides; Uridine; Vaccinia virus; Virus Replication; Xanthenes | 1974 |
49 other study(ies) available for camptothecin and Leukemia L 1210
Article | Year |
---|---|
Prodrug analogues of the antitumor alkaloid camptothecin.
Topics: Animals; Antineoplastic Agents; Camptothecin; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental | 1979 |
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1991 |
Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin.
Topics: Animals; Camptothecin; Leukemia L1210; Mice; Structure-Activity Relationship; Topoisomerase I Inhibitors | 1990 |
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chemical Phenomena; Chemistry; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Structure-Activity Relationship; Topoisomerase I Inhibitors | 1989 |
Plant antitumor agents. 22. Isolation of 11-hydroxycamptothecin from Camptotheca acuminata Decne: total synthesis and biological activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Isomerism; Leukemia L1210; Mice; Structure-Activity Relationship | 1986 |
Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Leukemia L1210; Solubility; Structure-Activity Relationship | 1986 |
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Humans; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred DBA; Molecular Conformation; Molecular Structure; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1993 |
Synthesis and cytotoxic activity of pyridazino[1',6':1,2]pyrido[3,4-b]indol-5-inium derivatives as anti-cancer agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Indoles; Leukemia L1210; Tumor Cells, Cultured | 2002 |
Synthesis and preliminary anticancer evaluation of 10-hydroxycamptothecin analogs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptotheca; Camptothecin; Cell Line, Tumor; Leukemia L1210; Phytotherapy; Plant Extracts; Treatment Outcome | 2012 |
Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colonic Neoplasms; DNA; Doxorubicin; Female; Glutathione; Glutathione Transferase; Guanidines; Irinotecan; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred DBA; Mice, Nude; Pyrroles; Transplantation, Heterologous | 2003 |
Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Docosahexaenoic Acids; Drug Design; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Mice; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship | 2005 |
Synthesis and antitumor activity of 20(S)-camptothecin derivatives. A-ring-substituted 7-ethylcamptothecins and their E-ring-modified water-soluble derivatives.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chemical Phenomena; Chemistry, Physical; Drug Screening Assays, Antitumor; Female; Humans; KB Cells; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Plants, Medicinal; Topoisomerase I Inhibitors | 1994 |
Chemical modification of antitumor alkaloids, 20(S)-camptothecin and 7-ethylcamptothecin: reaction of the E-lactone ring portion with hydrazine hydrate.
Topics: Animals; Camptothecin; Female; Hydrazines; Leukemia L1210; Mice | 1993 |
Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: E-lactone ring-modified water-soluble derivatives of 7-ethylcamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Lactones; Leukemia L1210; Mice; Solubility; Water | 1993 |
Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Humans; Leukemia L1210; Leukemia P388; Lipids; Metabolic Clearance Rate; Mice; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Cytotoxic efficacy with combinations of topoisomerase I and topoisomerase II inhibitors in sensitive and multidrug-resistant L1210 mouse leukemia cells.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Multiple; Drug Synergism; Enzyme Inhibitors; Etoposide; Leukemia L1210; Mice; Mitoxantrone; Topoisomerase I Inhibitors; Topotecan | 1996 |
Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH.
Topics: Animals; Antineoplastic Agents; Camptothecin; DNA, Neoplasm; Hydrogen-Ion Concentration; Leukemia L1210; Mice; Mice, Inbred C3H; Topotecan | 1997 |
Pentoxifylline stimulates drug-induced apoptosis in leukemic cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Cycle; Cell Division; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; G2 Phase; Leukemia L1210; Mice; Pentoxifylline; Stimulation, Chemical | 1998 |
Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Disease Models, Animal; DNA; Drug Screening Assays, Antitumor; Drug Stability; Enzyme Inhibitors; HT29 Cells; Humans; K562 Cells; Lactones; Leukemia L1210; Leukemia, Experimental; Neoplasm Transplantation; Topoisomerase I Inhibitors; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; DNA Damage; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Etoposide; Leukemia L1210; Nucleic Acid Synthesis Inhibitors; Proteins; Quinazolines; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |
Isolation and chemical characterization of antitumor agents from plants.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carubicin; Chemical Fractionation; Chemical Phenomena; Chemistry; Chromatography; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Countercurrent Distribution; Humans; Leukemia L1210; Leukemia, Experimental; Longevity; Mice; Neoplasms; Plant Extracts; Spectrum Analysis | 1976 |
Analogs of camptothecin.
Topics: Animals; Camptothecin; Carcinoma; Cell Line; Leukemia L1210; Mouth Neoplasms | 1975 |
Experiments of synthesis of dl-camptothecin. 4. Synthesis and antileukemic activity of dl-camptothecin analogues.
Topics: Animals; Camptothecin; Female; Leukemia L1210; Mice; Mice, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1976 |
Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: glycosides, phosphates and sulfates of 7-ethyl-10-hydroxycamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Glycosides; Irinotecan; Leukemia L1210; Mice; Mice, Inbred Strains; Phosphates; Sulfates | 1992 |
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
Topics: Animals; Base Sequence; Camptothecin; DNA Topoisomerases, Type I; DNA, Neoplasm; Hydrolysis; Leukemia L1210; Mice; Molecular Sequence Data; Substrate Specificity | 1991 |
Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
Topics: Animals; Benzimidazoles; Bisbenzimidazole; Camptothecin; Cell Nucleus; Distamycins; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Interactions; Indoles; Leukemia L1210; Molecular Structure; Pyrroles; Topoisomerase I Inhibitors | 1990 |
Chemical modification of an antitumor alkaloid camptothecin: synthesis and antitumor activity of 7-C-substituted camptothecins.
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Leukemia L1210; Mice; Structure-Activity Relationship | 1991 |
Synthesis and antitumor activity of 20(S)-camptothecin derivatives: A-ring modified and 7,10-disubstituted camptothecins.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Survival; Female; Humans; KB Cells; Leukemia L1210; Mice; Mice, Inbred Strains | 1991 |
[Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 leukemia].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Cyclophosphamide; Female; Irinotecan; Leukemia L1210; Methotrexate; Mice; Mitomycin; Mitomycins; Thioinosine | 1991 |
Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carbamates; Female; Irinotecan; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Solubility; Water | 1991 |
Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
Topics: Animals; Camptothecin; DNA, Neoplasm; Humans; Interphase; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid; Mice; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1990 |
[Effect of administration schedules on the antitumor activity of CPT-11, a camptothecin derivative].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Fibrosarcoma; Injections, Intraperitoneal; Injections, Intravenous; Irinotecan; Leukemia L1210; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental | 1990 |
Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotransformation; Camptothecin; Cell Division; Irinotecan; Kinetics; Leukemia L1210; Mice; Mice, Inbred Strains; Tissue Distribution; Tumor Cells, Cultured | 1990 |
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Topics: Animals; Camptothecin; Cell Survival; DNA Damage; DNA Topoisomerases, Type I; DNA, Circular; DNA, Neoplasm; Dose-Response Relationship, Drug; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Structure-Activity Relationship | 1989 |
Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
Topics: Animals; Aphidicolin; Camptothecin; Cattle; Cell Survival; Diterpenes; DNA Damage; DNA Replication; DNA, Viral; Kinetics; Leukemia L1210; Mice; Simian virus 40; Thymus Gland; Topoisomerase I Inhibitors; Tumor Stem Cell Assay | 1989 |
Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
Topics: Animals; Camptothecin; Cell Line; Cross-Linking Reagents; DNA Damage; DNA, Viral; Leukemia L1210; Mice; Simian virus 40; Topoisomerase I Inhibitors | 1988 |
Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.
Topics: Animals; Camptothecin; DNA Damage; DNA, Neoplasm; Leukemia L1210; Mice; Neoplasm Proteins; Topoisomerase I Inhibitors | 1987 |
[Antitumor activity of new derivatives of camptothecin].
Topics: Animals; Antineoplastic Agents; Camptothecin; Doxorubicin; Irinotecan; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred ICR; Neoplasms, Experimental | 1987 |
Antitumor activity of a new camptothecin derivative, SN-22, against various murine tumors.
Topics: Animals; Antineoplastic Agents; Camptothecin; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1987 |
Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure-activity correlations.
Topics: Animals; Camptothecin; Cell Line; Leukemia L1210; Plant Extracts; Structure-Activity Relationship | 1987 |
Action of 7-ethylcamptothecin on tumor cells and its disposition in mice.
Topics: Animals; Camptothecin; Cell Cycle; Cell Division; Chromatography, High Pressure Liquid; Female; Flow Cytometry; Kinetics; Leukemia L1210; Mice; Tissue Distribution | 1987 |
Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
Topics: Acridines; Acrylamides; Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzazepines; Camptothecin; Carbazoles; Carbon Isotopes; Cell Nucleolus; Cell Nucleus; Centrifugation, Density Gradient; Dactinomycin; Daunorubicin; Deoxyadenosines; DNA, Neoplasm; Ethidium; Leukemia L1210; Mechlorethamine; Methionine; Phenanthridines; Pyridines; Pyrroles; RNA, Neoplasm; Tritium; Uridine | 1972 |
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
Topics: Amines; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Carmustine; Chlorides; Cyclophosphamide; Cytarabine; Drug Synergism; Emetine; Fluorouracil; Ketones; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperazines; Platinum; Propane; Time Factors | 1973 |
Potentially useful combinations of chemotherapy detected in mouse tumor systems.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Azauridine; Bleomycin; Camptothecin; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethylamines; Fluorouracil; Imidazoles; Leukemia L1210; Lung Neoplasms; Methotrexate; Mice; Neoplasms, Experimental; Oxazines; Piperazines; Procarbazine; Propane; Triazenes | 1974 |
Action of camptothecin on mammalian cells in culture.
Topics: Animals; Camptothecin; Cell Line; Cell Survival; Cricetinae; Deoxyuridine; DNA Nucleotidyltransferases; DNA Replication; DNA, Neoplasm; Leukemia L1210; Lung; Mitosis; Neoplasms, Experimental; Phosphotransferases; RNA, Neoplasm; Thymidine Kinase; Time Factors; Tritium | 1972 |
The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Survival; Cytarabine; DNA, Neoplasm; Formates; Hydroxyurea; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pyridines; Thiosemicarbazones; Thymidine; Time Factors | 1973 |
Cell-kill kinetics of several S-phase-specific drugs.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Line; Cell Survival; Cricetinae; Cytarabine; DNA, Neoplasm; Formates; Hydroxyurea; Kinetics; Leukemia L1210; Lung; Mice; Neoplasms, Experimental; Pyridines; Thiosemicarbazones; Time Factors | 1973 |
Effects of camptothecin on RNA synthesis in L-1210 cells.
Topics: Animals; Camptothecin; Carbon Isotopes; Centrifugation, Density Gradient; Clone Cells; Leukemia L1210; Methylation; Mice; Nucleotides; Phosphorus Isotopes; RNA; RNA, Ribosomal; Time Factors; Uridine | 1973 |